Pandolfo M, Manto M. Cerebellar and afferent ataxias. Continuum (Minneap Minn) 2013; 19:1312-1343.
Linnemann C, Tezenas du Montcel S, Rakowicz M, et al. Peripheral neuropathy in spinocerebellar ataxia type 1, 2, 3, and 6. Cerebellum 2016; 15:165-173.
Higuchi Y, Hashiguchi A, Yuan J., et al. Mutations in MME cause an autosomal-recessive Charcot-Marie-Tooth disease type 2. Ann Neurol 2016; 79:659-672.
Gu S, Fang L, Xu X. Using SOAPaligner for short reads alignment. Curr Protoc Bioinformatics 2013; 44:11.11.1-11.11.17.
MacArthur DG, Manolio TA, Dimmock D.P., et al. Guidelines for investigating causality of sequence variants in human disease. Nature 2014; 508:469-476.
Pyle A, Smertenko T, Bargiela D., et al. Exome sequencing in undiagnosed inherited and sporadic ataxias. Brain 2015; 138:276-283.
Fukami S, Watanabe K, Iwata N., et al. Abeta-degrading endopeptidase, neprilysin, in mouse brain: synaptic and axonal localization inversely correlating with Abeta pathology. Neurosci Res 2002; 43:39-56.
Kioussi C, Matsas R. Endopeptidase-24.11, a cell-surface peptidase of central nervous system neurons, is expressed by Schwann cells in the pig peripheral nervous system. J Neurochem 1991; 57:431-440.
Ohkushi G, Suzuki N, Kobayashi S., Chikuma T. Axonal transport of neprilysin in rat sciatic nerves. J Mol Neurosci 2014; 53:96-102.
Oefner C, D'Arcy A, Hennig M, Winkler F.K., Dale GE. Structure of human neutral endopeptidase (Neprilysin) complexed with phosphoramidon. J Mol Biol 2000; 296:341-349.
Iwata N, Higuchi M, Saido TC Metabolism of amyloid-beta peptide and Alzheimer's disease. Pharmacol Ther 2005; 108:129-148.
Iwata N, Tsubuki S, Takaki Y., et al. Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nat Med 2000; 6:143-150.
Madani R, Poirier R, Wolfer D.P., et al. Lack of neprilysin suffices to generate murine amyloid-like deposits in the brain and behavioral deficit in vivo. J Neurosci Res 2006; 84:1871-1878.
Walther T, Albrecht D, Becker M., et al. Improved learning and memory in aged mice deficient in amyloid beta-degrading neutral endopeptidase. PLoS One 2009; 4:e4590.
Clarimon J, Muñoz FJ, Boada M., et al. Possible increased risk for Alzheimer's disease associated with neprilysin gene. J Neural Transm (Vienna) 2003; 110:651-657.
Bakalkin G, Watanabe H, Jezierska J., et al. Prodynorphin mutations cause the neurodegenerative disorder spinocere-bellar ataxia type 23. Am J Hum Genet 2010; 87:593-603.
Smeets CJLM, Jezierska J, Watanabe H., et al. Elevated mutant dynorphin A causes Purkinje cell loss and motor dysfunction in spinocerebellar ataxia type 23. Brain 2015; 138:2537-2552.
Martin-Kleiner I., Balog T, Marotti T. Dynorphin inhibits NEP activity in R1.1 mouse thymoma cells. Cell Biochem Funct 2008; 26:916-919.
